The most common route of administration used during COVID-19
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the virus that caused the COVID-19 pandemic. Initial symptoms include fever, cough, and dyspnea. Symptoms include nausea, vomiting, and abdominal pain, GIT involvement is also possible. The COVID-19 outbreak has increased the need...
Main Authors: | Mena Raid Khalil, Ghaidaa S. Hameed, Dalya Basil Hanna |
---|---|
Format: | Article |
Language: | English |
Published: |
College of Pharmacy / Mustansiriyah University
2023-03-01
|
Series: | Al-Mustansiriyah Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/990 |
Similar Items
-
Preparation and Evaluation of Azithromycin as Rectal Suppository to Treat Bacterial Infection of COVID-19
by: Mena Raid Khalil, et al.
Published: (2023-12-01) -
The possible techniques that used to improve the bioavailablity, pharmacological activity, solubility and permeability of anti-viral drugs: Insight for COVID-19 antiviral drugs
by: Ghassan Mudher Hashim, et al.
Published: (2023-07-01) -
Most Common Long COVID Physical Symptoms in Working Age Adults Who Experienced Mild COVID-19 Infection: A Scoping Review
by: Zoe Mass Kokolevich, et al.
Published: (2022-12-01) -
Do COVID-19 Vaccinations Affect the Most Common Post-COVID Symptoms? Initial Data from the STOP-COVID Register–12-Month Follow-Up
by: Mateusz Babicki, et al.
Published: (2023-06-01) -
Formulation Strategies of Nanosuspensions for Various Administration Routes
by: Sıla Gülbağ Pınar, et al.
Published: (2023-05-01)